All HCV drugs that started their first US clinical trial in patients (as opposed to healthy volunteers) during the past year or so have been subject to the FDA’s 3-day limit on monotherapy testing (#msg-31044983). In addition to IDX184, such drugs include ANA598 and ACH-1095.
Market Data 
Markets 
AI
